A specific B2-bradykinin receptor antagonist HOE 140 abolishes the antihypertrophic effect of ramipril.

Por Linz, W., Schölkens, B. A.
Publicado em 1992

Ramipril prevents left ventricular hypertrophy with myocardial fibrosis without blood pressure reduction: a one year study in rats.

Por Linz, W., Schaper, J., Wiemer, G., Albus, U., Schölkens, B. A.
Publicado em 1992

Ramiprilat increases bradykinin outflow from isolated hearts of rat.

Por Baumgarten, C. R., Linz, W., Kunkel, G., Schölkens, B. A., Wiemer, G.
Publicado em 1993

Hoe 694, a new Na+/H+ exchange inhibitor and its effects in cardiac ischaemia.

Por Scholz, W., Albus, U., Lang, H. J., Linz, W., Martorana, P. A., Englert, H. C., Schölkens, B. A.
Publicado em 1993

Hoe 140 a new potent and long acting bradykinin-antagonist: in vivo studies

Por Wirth, K., Hock, F.J., Albus, U., Linz, W., Alpermann, H.G., Anagnostopoulos, H., Henke, St., Breipohl, G., König, W., Knolle, J., Schölkens, B.A.
Publicado em 1991

Hoe 140 a new potent and long acting bradykinin-antagonist: in vitro studies

Por Hock, F.J., Wirth, K., Albus, U., Linz, W., Gerhards, H.J., Wiemer, G., Henke, St., Breipohl, G., König, W., Knolle, J., Schölkens, B.A.
Publicado em 1991

Discovery and pharmacological characterization of a novel potent inhibitor of diacylglycerol-sensitive TRPC cation channels

Por Maier, T, Follmann, M, Hessler, G, Kleemann, H-W, Hachtel, S, Fuchs, B, Weissmann, N, Linz, W, Schmidt, T, Löhn, M, Schroeter, K, Wang, L, Rütten, H, Strübing, C
Publicado no Br J Pharmacol (2015)